A phase II randomized controlled trial on effect of digestive enzymes for the development of nonalcoholic fatty liver disease (NAFLD) after pancreaticoduodenectomy.
Phase 2
Recruiting
- Conditions
- Patients who need pancreaticoduodenectomy
- Registration Number
- JPRN-UMIN000017266
- Lead Sponsor
- ational Defense Medical College
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 100
Inclusion Criteria
Not provided
Exclusion Criteria
Preoperative fatty liver Positive HBs antigen or HCV antibody alcohol abuse total pancreatectomy R2 operation Gastrointestinal disease with malabsorption Other reason that attending doctors consider
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The incidence of non alcoholic fatty liver disease one year after surgery
- Secondary Outcome Measures
Name Time Method The nutritional status, pancreatic endocrine and exocrine function one year after surgery